Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 1803 of 3330
Next
>>
>
45051 to 45075 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
BT-483	HR+	Luminal	LBH589	HDAC	HDAC	0.267	uM	10696.154	0.5743	-0.1979	0.6070
BT-483	HR+	Luminal	LBH589	HDAC	HDAC	1.33	uM	10696.154	0.2694	-0.7695	0.6070
BT-483	HR+	Luminal	LBH589	HDAC	HDAC	6.67	uM	10696.154	0.1912	-0.8690	0.6070
BT-483	HR+	Luminal	LBH589	HDAC	HDAC	33.3	uM	10696.154	0.1545	-0.9078	0.6070
BT-483	HR+	Luminal	LBH589	HDAC	HDAC	0.0000853	uM	11855.154	0.9825	0.9447	0.6282
BT-483	HR+	Luminal	LBH589	HDAC	HDAC	0.000427	uM	11855.154	0.8984	0.6865	0.6282
BT-483	HR+	Luminal	LBH589	HDAC	HDAC	0.00213	uM	11855.154	0.9998	0.9993	0.6282
BT-483	HR+	Luminal	LBH589	HDAC	HDAC	0.0107	uM	11855.154	0.9571	0.8652	0.6282
BT-483	HR+	Luminal	LBH589	HDAC	HDAC	0.0533	uM	11855.154	0.8374	0.5077	0.6282
BT-483	HR+	Luminal	LBH589	HDAC	HDAC	0.267	uM	11855.154	0.5627	-0.1993	0.6282
BT-483	HR+	Luminal	LBH589	HDAC	HDAC	1.33	uM	11855.154	0.2635	-0.7607	0.6282
BT-483	HR+	Luminal	LBH589	HDAC	HDAC	6.67	uM	11855.154	0.2149	-0.8270	0.6282
BT-483	HR+	Luminal	LBH589	HDAC	HDAC	33.3	uM	11855.154	0.1874	-0.8610	0.6282
BT-549	TNBC	Basal B	LBH589	HDAC	HDAC	0.0000853	uM	12305.167	1.0605	1.0412	2.8814
BT-549	TNBC	Basal B	LBH589	HDAC	HDAC	0.000427	uM	12305.167	0.9789	0.9853	2.8814
BT-549	TNBC	Basal B	LBH589	HDAC	HDAC	0.00213	uM	12305.167	1.0390	1.0267	2.8814
BT-549	TNBC	Basal B	LBH589	HDAC	HDAC	0.0107	uM	12305.167	0.9550	0.9683	2.8814
BT-549	TNBC	Basal B	LBH589	HDAC	HDAC	0.0533	uM	12305.167	0.7461	0.8067	2.8814
BT-549	TNBC	Basal B	LBH589	HDAC	HDAC	0.267	uM	12305.167	0.3425	0.3789	2.8814
BT-549	TNBC	Basal B	LBH589	HDAC	HDAC	1.33	uM	12305.167	0.0809	-0.1642	2.8814
BT-549	TNBC	Basal B	LBH589	HDAC	HDAC	6.67	uM	12305.167	0.0180	-0.5040	2.8814
BT-549	TNBC	Basal B	LBH589	HDAC	HDAC	33.3	uM	12305.167	0.0114	-0.5767	2.8814
CAMA-1	HR+	Luminal	LBH589	HDAC	HDAC	0.0000853	uM	10755.154	0.9446	0.8914	1.0198
CAMA-1	HR+	Luminal	LBH589	HDAC	HDAC	0.000427	uM	10755.154	0.8991	0.8019	1.0198
CAMA-1	HR+	Luminal	LBH589	HDAC	HDAC	0.00213	uM	10755.154	0.9804	0.9615	1.0198

|<
<<
Previous
Page 1803 of 3330
Next
>>
>
45051 to 45075 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)